Filter By Industry
Filter By Tag

Newsroom

Su Zhou Hepa Thera Biotech Ltd. Press releases

1 - 1 of 1 Press Release

Hepa Thera's HT101 Secures Breakthrough Therapy Designation from China CDE for Chronic Hepatitis B
Jul 16, 2025
– Landmark regulatory milestone highlights HT101's monotherapy potential to drive HBsAg clearance without immunomodulators – HT101 + HT102 combination shows compelling synergy; additional BTD under consideration


Su Zhou Hepa Thera Biotech Ltd. RSS Feed